Functional characterization of CDK10 and cyclin M truncated variants causing severe developmental disorders
Abstract Background CDK10 is a poorly known cyclin M (CycM)‐dependent kinase. Loss‐of‐function mutations in the genes encoding CycM or CDK10 cause, respectively, STAR or Al Kaissi syndromes, which present a constellation of malformations and dysfunctions. Most reported mutations abolish gene express...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a9b71a335ec247d798d8c68cdf527e63 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:a9b71a335ec247d798d8c68cdf527e63 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:a9b71a335ec247d798d8c68cdf527e632021-11-10T16:39:23ZFunctional characterization of CDK10 and cyclin M truncated variants causing severe developmental disorders2324-926910.1002/mgg3.1782https://doaj.org/article/a9b71a335ec247d798d8c68cdf527e632021-10-01T00:00:00Zhttps://doi.org/10.1002/mgg3.1782https://doaj.org/toc/2324-9269Abstract Background CDK10 is a poorly known cyclin M (CycM)‐dependent kinase. Loss‐of‐function mutations in the genes encoding CycM or CDK10 cause, respectively, STAR or Al Kaissi syndromes, which present a constellation of malformations and dysfunctions. Most reported mutations abolish gene expression, but two mutations found in 3’ exons could allow the expression of CDK10 and CycM truncated variants. Methods We built a structural model that predicted a preserved ability of both variants to form a CDK10/CycM heterodimer. Hence, we functionally characterized these two truncated variants by determining their capacity to heterodimerize and form an active protein kinase when expressed in insect cells, by examining their two‐hybrid interaction profiles when expressed in yeast, and by observing their expression level and stability when expressed in human cells. Results Both truncated variants retain their ability to form a CDK10/CycM heterodimer. While the CycM variant partially activates CDK10 activity in vitro, the CDK10 variant remains surprisingly inactive. Expression in human cells revealed that the CDK10 and CycM variants are strongly and partially degraded by the proteasome, respectively. Conclusion Our results point to a total loss of CDK10/CycM activity in the Al Kaissi patient and a partial loss in the STAR patients.Thomas RobertAnne‐Catherine Dock‐BregeonPierre ColasWileyarticleAl Kaissi syndromeCDK10cyclin Minteraction profilingprotein kinaseSTAR syndromeGeneticsQH426-470ENMolecular Genetics & Genomic Medicine, Vol 9, Iss 10, Pp n/a-n/a (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Al Kaissi syndrome CDK10 cyclin M interaction profiling protein kinase STAR syndrome Genetics QH426-470 |
spellingShingle |
Al Kaissi syndrome CDK10 cyclin M interaction profiling protein kinase STAR syndrome Genetics QH426-470 Thomas Robert Anne‐Catherine Dock‐Bregeon Pierre Colas Functional characterization of CDK10 and cyclin M truncated variants causing severe developmental disorders |
description |
Abstract Background CDK10 is a poorly known cyclin M (CycM)‐dependent kinase. Loss‐of‐function mutations in the genes encoding CycM or CDK10 cause, respectively, STAR or Al Kaissi syndromes, which present a constellation of malformations and dysfunctions. Most reported mutations abolish gene expression, but two mutations found in 3’ exons could allow the expression of CDK10 and CycM truncated variants. Methods We built a structural model that predicted a preserved ability of both variants to form a CDK10/CycM heterodimer. Hence, we functionally characterized these two truncated variants by determining their capacity to heterodimerize and form an active protein kinase when expressed in insect cells, by examining their two‐hybrid interaction profiles when expressed in yeast, and by observing their expression level and stability when expressed in human cells. Results Both truncated variants retain their ability to form a CDK10/CycM heterodimer. While the CycM variant partially activates CDK10 activity in vitro, the CDK10 variant remains surprisingly inactive. Expression in human cells revealed that the CDK10 and CycM variants are strongly and partially degraded by the proteasome, respectively. Conclusion Our results point to a total loss of CDK10/CycM activity in the Al Kaissi patient and a partial loss in the STAR patients. |
format |
article |
author |
Thomas Robert Anne‐Catherine Dock‐Bregeon Pierre Colas |
author_facet |
Thomas Robert Anne‐Catherine Dock‐Bregeon Pierre Colas |
author_sort |
Thomas Robert |
title |
Functional characterization of CDK10 and cyclin M truncated variants causing severe developmental disorders |
title_short |
Functional characterization of CDK10 and cyclin M truncated variants causing severe developmental disorders |
title_full |
Functional characterization of CDK10 and cyclin M truncated variants causing severe developmental disorders |
title_fullStr |
Functional characterization of CDK10 and cyclin M truncated variants causing severe developmental disorders |
title_full_unstemmed |
Functional characterization of CDK10 and cyclin M truncated variants causing severe developmental disorders |
title_sort |
functional characterization of cdk10 and cyclin m truncated variants causing severe developmental disorders |
publisher |
Wiley |
publishDate |
2021 |
url |
https://doaj.org/article/a9b71a335ec247d798d8c68cdf527e63 |
work_keys_str_mv |
AT thomasrobert functionalcharacterizationofcdk10andcyclinmtruncatedvariantscausingseveredevelopmentaldisorders AT annecatherinedockbregeon functionalcharacterizationofcdk10andcyclinmtruncatedvariantscausingseveredevelopmentaldisorders AT pierrecolas functionalcharacterizationofcdk10andcyclinmtruncatedvariantscausingseveredevelopmentaldisorders |
_version_ |
1718439902618583040 |